{"id":1987,"date":"2026-10-20T14:31:01","date_gmt":"2026-10-20T06:31:01","guid":{"rendered":"https:\/\/www.vcro.com.tw\/?p=1987"},"modified":"2026-10-20T14:31:15","modified_gmt":"2026-10-20T06:31:15","slug":"congratulations-vcro-supports-ucar-t-phase-ii-trial-for-brain-metastases-from-solid-tumors-receiving-u-s-fda-authorization-to-proceed","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=1987","title":{"rendered":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed"},"content":{"rendered":"\n<p>With support from VCRO\u2019s expert team, a client\u2019s Phase II clinical trial of universal allogeneic chimeric antigen receptor T-cell (UCAR-T) therapy for brain metastases from advanced solid tumors has received U.S. FDA authorization to proceed in October 2026. VCRO supported the clinical development strategy, trial design, and integration of regulatory materials and communications.<br>Since 2008, VCRO has been active in the cell therapy field, building extensive experience in the clinical development of cell and regenerative medicine products. To date, the company has supported more than 57 related projects. From early development strategy and trial design to regulatory submissions, communications with regulatory authorities, and the launch and execution of multinational clinical trials, VCRO offers comprehensive, end-to-end services. Our experience helps clients navigate regulatory and operational hurdles and move their products toward the next key milestone.<br>If you are planning clinical development in Taiwan or the United States for cell therapies, regenerative medicine, advanced therapies, or other innovative medicines, please submit an inquiry through the VCRO website to contact our expert team. We look forward to working with you to develop the right product development and international clinical strategy for your needs.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png\" alt=\"UCAR-T\" class=\"wp-image-1988\"\/><figcaption class=\"wp-element-caption\">UCAR-T<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>With support from VCRO\u2019s expert team, a client\u2019s Phase II clinical trial of universal allogeneic chimeric antigen receptor T-cell (UCAR-T) therapy for brain metastases from advanced solid tumors has received U.S. FDA authorization to proceed in October 2026. VCRO supported the clinical development strategy, trial design, and integration of regulatory materials and communications.Since 2008, VCRO [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1988,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[15,19],"class_list":["post-1987","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vcro-express","tag-cell-therapy","tag-vcro"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed - VCRO<\/title>\r\n<meta name=\"description\" content=\"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed VCRO VCRO express -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=1987\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed VCRO VCRO express -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=1987\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2026-10-20T06:31:01+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2026-10-20T06:31:15+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:height\" content=\"683\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed\",\"datePublished\":\"2026-10-20T06:31:01+00:00\",\"dateModified\":\"2026-10-20T06:31:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987\"},\"wordCount\":211,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png\",\"keywords\":[\"Cell therapy\",\"VCRO\"],\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=1987\",\"name\":\"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png\",\"datePublished\":\"2026-10-20T06:31:01+00:00\",\"dateModified\":\"2026-10-20T06:31:15+00:00\",\"description\":\"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed VCRO VCRO express -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=1987\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987#primaryimage\",\"url\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png\",\"contentUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png\",\"width\":1536,\"height\":1024,\"caption\":\"UCAR-T\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1987#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed - VCRO","description":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed VCRO VCRO express -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=1987","og_locale":"en_US","og_type":"article","og_title":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed - VCRO","og_description":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed VCRO VCRO express -","og_url":"https:\/\/www.vcro.com.tw\/?p=1987","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2026-10-20T06:31:01+00:00","article_modified_time":"2026-10-20T06:31:15+00:00","og_image":[{"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png","width":1024,"height":683,"type":"image\/png"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=1987#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=1987"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed","datePublished":"2026-10-20T06:31:01+00:00","dateModified":"2026-10-20T06:31:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1987"},"wordCount":211,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=1987#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png","keywords":["Cell therapy","VCRO"],"articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=1987","url":"https:\/\/www.vcro.com.tw\/?p=1987","name":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1987#primaryimage"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=1987#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png","datePublished":"2026-10-20T06:31:01+00:00","dateModified":"2026-10-20T06:31:15+00:00","description":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed VCRO VCRO express -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=1987#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=1987"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/?p=1987#primaryimage","url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png","contentUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2026\/10\/UCAR-T\u8166\u8f49\u79fb\u81e8\u5e8a\u8a66\u9a57\u6d41\u7a0b\u5716.png","width":1536,"height":1024,"caption":"UCAR-T"},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=1987#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Congratulations! VCRO Supports UCAR-T Phase II Trial for Brain Metastases from Solid Tumors, Receiving U.S. FDA Authorization to Proceed"}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1987"}],"version-history":[{"count":1,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1987\/revisions"}],"predecessor-version":[{"id":1989,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1987\/revisions\/1989"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/media\/1988"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}